Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 3
2015 3
2016 3
2017 5
2018 8
2019 12
2020 17
2021 16
2022 13
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year

Citations

2 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.
Samanta D. Samanta D. Pediatr Neurol. 2019 Jul;96:24-29. doi: 10.1016/j.pediatrneurol.2019.03.014. Epub 2019 Mar 22. Pediatr Neurol. 2019. PMID: 31053391 Review.
Because many of these patients are not candidates for curative epilepsy surgery, there is a need for new seizure medicines with better efficacy and safety profile. ...The US Food and Drug Administration (FDA) has approved pharmaceutical-grade cannabidiol
Because many of these patients are not candidates for curative epilepsy surgery, there is a need for new seizure medicines with bette …
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M. Lattanzi S, et al. Drugs. 2018 Nov;78(17):1791-1804. doi: 10.1007/s40265-018-0992-5. Drugs. 2018. PMID: 30390221
BACKGROUND: Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. ...In contrast to tetra-hydrocannabinol, CBD lacks psychoactive properties, does not produce e …
BACKGROUND: Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is th …
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
However, there is a lack of well-controlled, double blind, randomized clinical trials to provide clarity on the efficacy of either delta(9)-THC or CBD as therapeutics. ...The legalization of cannabis for medicinal purposes and for recreational use in some regions wi …
However, there is a lack of well-controlled, double blind, randomized clinical trials to provide clarity on the efficacy of ei …
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis.
Treves N, Mor N, Allegaert K, Bassalov H, Berkovitch M, Stolar OE, Matok I. Treves N, et al. Sci Rep. 2021 Dec 6;11(1):23462. doi: 10.1038/s41598-021-02770-6. Sci Rep. 2021. PMID: 34873203 Free PMC article.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. ...Selection criteria included studies evaluating efficacy and safety outcomes of medical cannabinoids (tetrahydrocannab …
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncer …
Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S, Trinka E, Striano P, Rocchi C, Salvemini S, Silvestrini M, Brigo F. Lattanzi S, et al. CNS Drugs. 2021 Mar;35(3):265-281. doi: 10.1007/s40263-021-00807-y. Epub 2021 Mar 22. CNS Drugs. 2021. PMID: 33754312 Free PMC article.
In the European Union, the drug has been authorized by the European Medicines Agency for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome, in conjunction with clobazam, and is under regulatory review for the treatment of s …
In the European Union, the drug has been authorized by the European Medicines Agency for the treatment of seizures associated with Dr …
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.
Chesney E, Oliver D, Green A, Sovi S, Wilson J, Englund A, Freeman TP, McGuire P. Chesney E, et al. Neuropsychopharmacology. 2020 Oct;45(11):1799-1806. doi: 10.1038/s41386-020-0667-2. Epub 2020 Apr 8. Neuropsychopharmacology. 2020. PMID: 32268347 Free PMC article.
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety. ...After excluding studies in childhood epilepsy, the only adverse outcome associated with CBD treatment was d
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its saf
Update on Antiepileptic Drugs 2019.
Abou-Khalil BW. Abou-Khalil BW. Continuum (Minneap Minn). 2019 Apr;25(2):508-536. doi: 10.1212/CON.0000000000000715. Continuum (Minneap Minn). 2019. PMID: 30921021 Review.
Treatment of epilepsy starts with AED monotherapy. Knowledge of the spectrum of efficacy, clinical pharmacology, and modes of use for individual AEDs is essential for optimal treatment for epilepsy. ...Other newer AEDs with a variety of m
Treatment of epilepsy starts with AED monotherapy. Knowledge of the spectrum of efficacy, clinical pharmacology,
Dravet Syndrome: A Review of Current Management.
Wheless JW, Fulton SP, Mudigoudar BD. Wheless JW, et al. Pediatr Neurol. 2020 Jun;107:28-40. doi: 10.1016/j.pediatrneurol.2020.01.005. Epub 2020 Jan 31. Pediatr Neurol. 2020. PMID: 32165031 Review.
Three new medicines-stiripentol, cannabidiol, and fenfluramine-have documented efficacy and safety as adjunctive therapies for treating pharmacoresistant Dravet syndrome. ...Preventing status epilepticus and generalized tonic-clonic seizures could potentially …
Three new medicines-stiripentol, cannabidiol, and fenfluramine-have documented efficacy and safety as adjunctive therap …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Sarris J, et al. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
BACKGROUND: Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomit …
BACKGROUND: Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes. Medic …
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Poleg S, Golubchik P, Offen D, Weizman A. Poleg S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30171992 Review.
In this review we summarize the available pre-clinical and clinical data regarding the safety and effectiveness of medical cannabis, including CBD, in young ASD patients. Cannabidiol seems to be a candidate for the treatment of ASD. At pr …
In this review we summarize the available pre-clinical and clinical data regarding the safety and effectiveness …
73 results